Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Lilly Earnings Call: Zepbound and Mounjaro Updates

Lilly Earnings Call: Zepbound and Mounjaro Updates

FromOn The Pen: The Weekly Dose


Lilly Earnings Call: Zepbound and Mounjaro Updates

FromOn The Pen: The Weekly Dose

ratings:
Length:
28 minutes
Released:
Apr 30, 2024
Format:
Podcast episode

Description

Send us a Text Message.Dave Knapp does a deep dive into todays  Eli Lilly earnings call.https://www.onthepen.com/post/zepbound-vial-watch-eli-lilly-earnings-q1-2024MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinVenmo: OnThePenCa$h App: ManOnMounjaroSOCIAL LINKShttps://www.tiktok.com/@manonthemounjarohttps://twitter.com/ManOnMounjarohttps://instagram.com/manonthemounjarohttps://facebook.com/manonthemounjaroSupport the Show.Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!
Released:
Apr 30, 2024
Format:
Podcast episode

Titles in the series (31)

Get your weekly dose of everything in the news about incretin mimetic therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!